within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M02A_TopicalProductsForJointAndMuscularPain.M02AA13_Ibuprofen;

model Ibuprofen_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.5666666666666668e-06,
    adminDuration = 600,
    adminMass = 400 / 1000000,
    adminCount = 1,
    Vd = 0.009720000000000001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0105,
    k12 = 1.0833333333333335e-05,
    k21 = 1.0833333333333335e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ibuprofen_1</td></tr><tr><td>ATC code:</td><td>M02AA13_1</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>400</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>9.72</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.094</td><td>L/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) widely used for its analgesic, antipyretic, and anti-inflammatory effects. It is commonly used for the treatment of mild to moderate pain, inflammation, and fever. Ibuprofen is an over-the-counter medication and is approved for clinical use worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adults after a single intravenous administration.</p><h4>References</h4><ol><li><p>Jin, Y, et al., &amp; Wang, Z (2023). Comparison of intravenous ibuprofen pharmacokinetics between Caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 191 106587–None. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2023.106587\">10.1016/j.ejps.2023.106587</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37734467/\">https://pubmed.ncbi.nlm.nih.gov/37734467</a></p></li><li><p>Zhou, H, et al., &amp; Liu, Y (2016). Pharmacokinetics and tolerability of intravenous ibuprofen injection in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study . <i>International journal of clinical pharmacology and therapeutics</i> 54(11) 904–913. DOI:<a href=\"https://doi.org/10.5414/CP202603\">10.5414/CP202603</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27569737/\">https://pubmed.ncbi.nlm.nih.gov/27569737</a></p></li><li><p>Han, EE, et al., &amp; Shapiro, BJ (2004). Pharmacokinetics of Ibuprofen in children with cystic fibrosis. <i>Clinical pharmacokinetics</i> 43(3) 145–156. DOI:<a href=\"https://doi.org/10.2165/00003088-200443030-00001\">10.2165/00003088-200443030-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14871154/\">https://pubmed.ncbi.nlm.nih.gov/14871154</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.M.M02AA13_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ibuprofen_1;
